Article metrics

Download PDFPDF

TP011/#1536  A double-blind placebo-controlled phase III chemo-immunotherapy (Paclitaxel-carboplatin-oregovomab [PCO]) vs chemotherapy (Paclitaxel-carboplatin-placebo [PCP]) in patients with newly diagnosed, advanced epithelial ovarian cancer (EOC): FLORA-5/GOG-3035 study
Free

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2024

AbstractFullPdf
Nov 2023320024
Dec 202390010
Jan 20242203
Feb 20244704
Mar 20244105
Apr 20242801
May 20242302
Jun 20241300
Total584049